The need for a new tuberculosis vaccine is as urgent as ever, and now a local pharmaceutical company is joining the race to find one
Low vaccination levels and high number of health-compromised populations make the continent a ‘breeding ground for variants’ that pose a global risk
This content is restricted to subscribers only.
Join the M&G Community
Our commitment at the Mail & Guardian is to ensure every reader enjoys the finest experience. Join the M&G community and support us in delivering in-depth news to you consistently.
Subscribe
Subscription enables:
- – M&G community membership
- – independent journalism
- – access to all premium articles & features
- – a digital version of the weekly newspaper
- – invites to subscriber-only events
- – the opportunity to test new online features first
Already a subscriber?
Login here.
The World Health Organisation has enlisted a team of South African researchers to produce a new mRNA Covid-19 vaccine, but with no recipe to follow, it’s not an easy task
Vaccine roll-out will be easier now that Pfizer confirms the lifespan of its Covid-19 vaccine in a refrigerator is more than six times longer than first estimated
In mere months, Moderna transformed an old Polaroid factory in America into a state-of-the-art vaccine-production centre. Why can’t we do the same?
As Covid vaccines near the manufacturing stage, a look at two polio vaccines provides valuable historical insights